Home
Martine A. Rothblatt, Chairperson & CEO: United Therapeutics UTHR Sell · Filed 05/19
Trade details
- Type
- Insider sale
- Amount
- $1,293,786
- Shares · price
- 2,280 sh · $567.45 a share
- Held after
- 43,307 sh
- Trade date
- 26/05/18
- Filed
- 26/05/19
- Days to filing
- 1 days
Sold 5.0% of holdings
- Share of holding sold
- 5.0%
United Therapeutics trades, last 26 weeks
What else happened in United Therapeutics around then
Filed or reported within 30 days of the trade day · 04/18~06/17Martine A. Rothblatt's recent trades
- Martine A. Rothblatt
Planned sale10b5-1 planUnited Therapeutics
Planned sale10b5-1 planUnited Therapeutics
UTHR
$113.3M
209,000 sh
$113.3M
Filed 10/01
Traded 10/01
- Martine A. Rothblatt
Sell10b5-1 planUnited Therapeutics
Sell10b5-1 planUnited Therapeutics
UTHR
$1.1M
2,309 sh
$1.1M
Filed 09/30
Traded 09/29
- Martine A. Rothblatt
Sell10b5-1 planUnited Therapeutics
Sell10b5-1 planUnited Therapeutics
UTHR
$1M
2,135 sh
$1M
Filed 09/30
Traded 09/29
- Martine A. Rothblatt
Sell10b5-1 planUnited Therapeutics
Sell10b5-1 planUnited Therapeutics
UTHR
$664.2K
1,395 sh
$664.2K
Filed 09/30
Traded 09/29
- Martine A. Rothblatt
Sell10b5-1 planUnited Therapeutics
Sell10b5-1 planUnited Therapeutics
UTHR
$574.9K
1,200 sh
$574.9K
Filed 09/30
Traded 09/29